EST
AMPH icon

EA Series Trust’s Amphastar Pharmaceuticals AMPH Stock Holding History

EA Series Trust’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$1.01M Buy
+17,519
New +$777K 0.04% 609

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EA Series Trust's AMPH Position: Q2 2023 in Review

EA Series Trust opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2023: 17,519 shares worth $1.01M. The stake represents 0.04% of the portfolio and ranks #609 among its holdings.

246 funds tracked by Wall St. Rank hold AMPH as of Q2 2023.

  • EA Series Trust held 17,519 shares of Amphastar Pharmaceuticals worth $1.01M as of Q2 2023.
  • Amphastar Pharmaceuticals was a new EA Series Trust position in Q2 2023.
  • Amphastar Pharmaceuticals made up 0.04% of EA Series Trust's portfolio in Q2 2023, its #609 holding.
  • 246 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.